• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Xa 因子荧光底物的比较研究及其对低分子肝素定量的影响。

Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.

机构信息

Biomedical Diagnostics Institute, National Centre for Sensor Research, Dublin City University, Dublin 9, Ireland.

出版信息

Anal Bioanal Chem. 2011 Jan;399(2):691-700. doi: 10.1007/s00216-010-4314-3. Epub 2010 Oct 24.

DOI:10.1007/s00216-010-4314-3
PMID:20972772
Abstract

Low molecular weight heparins (LMWHs) are recognised as the preferred anticoagulants in the prevention and treatment of venous thromboembolism. Anti-Factor Xa (anti-FXa) levels are used to monitor the anticoagulant effect of LMWHs and such assays are routinely employed in hospital diagnostic laboratories. In this study, a fluorogenic anti-FXa assay was developed using a commercially available fluorogenic substrate with an attached 6-amino-1-naphthalene-sulfonamide (ANSN) fluorophore and was used for the determination of two LMWHs, enoxaparin and tinzaparin and the heparinoid, danaparoid. The assay was based on the complexation of heparinised plasma with 100 nM exogenous FXa and 25 μM of the fluorogenic substrate Mes-D-LGR-ANSN (C(2)H(5))(2) (SN-7). The assay was tested with pooled plasma samples spiked with anticoagulant concentrations in the range 0-1.6 U mL(-1). The statistically sensitive assay range was 0-0.4 U mL(-1) for enoxaparin and tinzaparin and 0-0.2 U mL(-1) for danaparoid, with assay variation typically below 10.5%. This assay was then compared with a previously published fluorogenic anti-FXa assay developed with the peptide substrate, methylsulfonyl-D: -cyclohexylalanyl-glycyl-arginine-7-amino-4-methylcoumarin acetate (Pefafluor FXa). Both assays were compared in terms of fluorescence intensity, lag times and sensitivity to anticoagulants.

摘要

低分子量肝素(LMWHs)被认为是预防和治疗静脉血栓栓塞症的首选抗凝剂。抗因子 Xa(抗 FXa)水平用于监测 LMWHs 的抗凝效果,并且此类测定通常在医院诊断实验室中进行。在这项研究中,使用市售的带有附着的 6-氨基-1-萘磺酰胺(ANSN)荧光团的荧光底物开发了荧光抗 FXa 测定法,并用于测定两种 LMWHs,依诺肝素和亭扎肝素以及肝素类药物达那肝素。该测定法基于肝素化血浆与 100 nM 外源性 FXa 和 25 μM 荧光底物 Mes-D-LGR-ANSN(C(2)H(5))(2)(SN-7)的络合。该测定法使用浓度范围为 0-1.6 U mL(-1)的抗凝剂的混合血浆样品进行了测试。对于依诺肝素和亭扎肝素,统计上灵敏的测定范围为 0-0.4 U mL(-1),对于达那肝素,测定范围为 0-0.2 U mL(-1),测定变异通常低于 10.5%。然后,将该测定法与先前使用肽底物(甲基磺酰基-D:-环己基丙氨酸-甘氨酸-精氨酸-7-氨基-4-甲基香豆素乙酸酯(Pefafluor FXa))开发的荧光抗 FXa 测定法进行了比较。就荧光强度,滞后时间和对抗凝剂的敏感性而言,比较了两种测定法。

相似文献

1
Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.Xa 因子荧光底物的比较研究及其对低分子肝素定量的影响。
Anal Bioanal Chem. 2011 Jan;399(2):691-700. doi: 10.1007/s00216-010-4314-3. Epub 2010 Oct 24.
2
Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.开发荧光抗因子 Xa 测定法以监测未分级和低分子量肝素。
Talanta. 2010 Jun 15;81(4-5):1725-30. doi: 10.1016/j.talanta.2010.03.030. Epub 2010 Mar 25.
3
Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays.新型荧光法抗 FXa 检测与两种商业抗 FXa 显色法的抗凝反应比较。
Thromb Res. 2011 Dec;128(6):e166-70. doi: 10.1016/j.thromres.2011.08.002. Epub 2011 Aug 27.
4
Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas.比较荧光法抗 FXa 测定法与中心实验室显色法抗 FXa 测定法在测定患者血浆中低分子肝素活性中的应用。
Thromb Res. 2011 Dec;128(6):e125-9. doi: 10.1016/j.thromres.2011.07.011. Epub 2011 Aug 7.
5
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.凝血酶生成试验在体外评估抗凝逆转方面优于传统检测方法。
Thromb Haemost. 2008 Aug;100(2):350-5.
6
Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.心血管手术中达那肝素钠抗凝的术中监测
J Vasc Surg. 1998 Mar;27(3):568-75. doi: 10.1016/s0741-5214(98)70336-2.
7
Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.普通肝素、低分子量肝素和类肝素对凝血血栓弹力图测定的影响。
Am J Clin Pathol. 2000 May;113(5):725-31. doi: 10.1309/Q4AE-BMCW-CQ7J-NUVT.
8
Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.两步荧光法和两步抗 Xa 法联合检测肝素伪造物和肝素中的蛋白质。
Anal Bioanal Chem. 2011 Jan;399(2):681-90. doi: 10.1007/s00216-010-4252-0. Epub 2010 Oct 16.
9
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data.使用国际外部质量数据监测接受间接 Xa 抑制剂治疗的患者的质量表现。
Clin Chem Lab Med. 2020 Oct 25;58(11):1921-1930. doi: 10.1515/cclm-2020-0130.
10
Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.直接凝血酶抑制剂和因子 Xa 抑制剂可影响稀释的凝血酶原时间,该时间可作为狼疮抗凝物的初始筛查。
Arch Pathol Lab Med. 2013 Jul;137(7):967-73. doi: 10.5858/arpa.2012-0236-OA.

引用本文的文献

1
[Advances in heparin structural analysis by chromatography technologies].[色谱技术在肝素结构分析中的进展]
Se Pu. 2023 Feb;41(2):107-121. doi: 10.3724/SP.J.1123.2022.07020.